@iamalexissolia's estrogen delivery claims, fact-checked

What did @iamalexissolia actually say?

The creator's core argument is that oral estrogen and non-oral forms like patches, gels, and injections are not interchangeable, and that taking pills exposes you to higher risks of blood clots, stroke, DVT, and pulmonary embolism. They also claim that sublingual dosing still routes through the digestive tract and liver, and that higher oral doses compound these risks. That last point about sublingual absorption is factually wrong, but the broader clot-risk argument has real clinical backing.

The video is aimed at a transgender HRT audience, which is worth noting because baseline cardiovascular risk profiles in that population differ from postmenopausal women, where most of the foundational research was conducted. The creator doesn't acknowledge that distinction at all.

Does the science back this up?

On the main claim, yes, with caveats. The first-pass hepatic metabolism of oral estrogen is well-documented, and its effect on coagulation factors is not seriously disputed in the literature.

The ESTHER study (Canonico et al., 2007, Circulation) is the landmark reference here. It found that oral estrogen was associated with a fourfold increased risk of venous thromboembolism compared to non-users, while transdermal estrogen showed no statistically significant increase. A 2016 meta-analysis by Sweetland et al. in the British Medical Journal reinforced this, finding oral routes consistently elevated clot risk while transdermal routes did not. The mechanism is well understood: oral estrogens increase hepatic synthesis of clotting factors, particularly factor VII and fibrinogen, while transdermal delivery bypasses this entirely by entering systemic circulation directly.

So the creator is pointing at something real. The problem is the framing, which is absolute and strips out important nuance around individual risk stratification.

What did they get wrong (or right)?

Let's start with the sublingual claim, because it's a clear error. The creator says that even dissolving a pill under your tongue means it "still goes through your digestive tract." That is incorrect. Sublingual absorption bypasses first-pass hepatic metabolism precisely because the sublingual mucosa delivers the drug directly into venous circulation. This is not a minor detail. It's the entire reason sublingual estradiol is sometimes used as an alternative to patches or injections in clinical practice.

On the broader clot risk claim, the creator gets the direction right but overstates the certainty. Phrases like "oral estrogen leads to a high risk of strokes" present this as a guaranteed outcome rather than a probabilistic one that depends heavily on baseline risk factors, dose, formulation, and duration. A healthy 25-year-old on low-dose oral estradiol does not have the same absolute risk as a 55-year-old with a clotting disorder. The creator doesn't mention any of this.

What they got right: the hepatic first-pass distinction is real, the coagulation mechanism is real, and the clinical preference for transdermal routes in higher-risk patients is supported by current guidelines, including those from the Endocrine Society.

What should you actually know?

Route of administration matters, but your individual risk profile matters more. The evidence for transdermal estrogen carrying lower VTE risk is solid, particularly in populations with pre-existing clotting risk factors, obesity, smoking history, or factor V Leiden mutations. For people without those risk factors, the absolute risk difference between oral and transdermal routes is small, though not zero.

Sublingual estradiol occupies a legitimate middle ground in practice. Because it largely bypasses first-pass metabolism, its hepatic impact is closer to transdermal than to oral, though the pharmacokinetics are less predictable and peak levels can be variable (Wierckx et al., 2014, Journal of Sexual Medicine).

If you're on HRT or considering it, the conversation about route of administration belongs with a licensed clinician who can assess your actual cardiovascular and coagulation risk. This video is not that assessment. The creator is selling an ebook at the end, which does not disqualify the science they cite, but it's context worth having.